secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001493152-24-043241
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 1.01, 1.02, 2.04, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem gets merger support pacts; secured lenders terminate forbearance, declare default
--------------------------------------------------------------------------------

- Institutional investors with rights to ~1.09B common shares (via preferred, convertible notes, warrants) agreed to vote for Aditxt merger.
- Forbearance agreement terminated Oct 27 after Designated Agent (Future Pak) sent Amended Notice of Default citing new defaults, including HHS obligations.
- Default allows secured lenders to accelerate debt and exercise remedies under the SPA; prior forbearance covered only specified defaults.
- Company's merger with Aditxt (via Merger Sub) still pending; debt default may affect closing or require renegotiation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224043241/0001493152-24-043241-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315224043241/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-043241

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer